1. Early-drug development in the era of immuno-oncology: are we ready to face the challenges?. (26th June 2018) Authors: Ochoa de Olza, M; Oliva, M; Hierro, C; Matos, I; Martin-Liberal, J; Garralda, E Journal: Annals of oncology Issue: Volume 29:Number 8(2018) Page Start: 1727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1138PDFirst in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1. (23rd October 2018) Authors: Hansen, A; Bauer, T M; Moreno, V; Maio, M; Groenland, S; Martin-Liberal, J; Gan, H; Rischin, D; Millward, M; Olszanski, A J; Cho, D C; Paul, E; Ballas, M; Ellis, C; Zhou, H; Yadavilli, S; Sadik Shaik, J; Schmidt, E V; Hoos, A; Angevin, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1841PRefining criteria of hyperprogression (HPD) with immune checkpoint inhibitors (ICIs) to improve clinical applicability. (23rd October 2018) Authors: Matos Garcia, I; García Ruiz, A; Martin-Liberal, J; Hierro, C; Ochoa De Olza Amat, M; Viaplana, C; Mur, G; Vieito Villar, M; Brana, I; Azaro, A; Perez, C; Rodriguez Freixinos, V; Argiles, G; Oliveira, M; Felip Font, E; Muñoz-Couselo, E; Tabernero, J; Dienstmann, R; Garralda, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 143PTumor infiltrating lymphocytes (TILs) and PDL1 expression as prescreening enrichment biomarkers of clinical benefit to immune checkpoint inhibitors (CI) in early clinical trials (ECT). (23rd October 2018) Authors: Martin-Liberal, J; Pagliuca, F; Hierro, C; Viaplana, C; Muñoz Couselo, E; Capdevila, J; Matos, I; Fariñas Madrid, L; Zamora, E; Braña Garcia, I; Elez Fernandez, E; Ochoa De Olza Amat, M; Azaro, A; Alsina, M; Vieito Villar, M; Fasani, R; Tabernero, J; Garralda, E; Dienstmann, R; Nuciforo, P G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 110PImmune prognostic index (IPI) and hyper-progressive disease (HPD) in patients (pts) exposed to targeted agents (TAs) in phase I trials (Ph1T): Can lessons from immune checkpoint inhibitors (ICIs) be translated to other scenarios?. (23rd October 2018) Authors: Matos Garcia, I; Azaro, A; Viaplana, C; Hierro, C; Martin-Liberal, J; Brana, I; Gardeazabal, I; Gomila, P; Vieito Villar, M; Ochoa De Olza Amat, M; Elez Fernandez, E; Oliveira, M; Oaknin, A; Verdaguer, H; Navarro Mendivil, A; Alsina, M; Tabernero, J; Macarulla Mercade, T; Dienstmann, R; Garralda, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 92PVall d'Hebron Institute of Oncology (VHIO) immuno-oncology prognostic index (VIO): A new tool for improved patient (pt) selection in phase I (Ph1) trials with immune checkpoint inhibitors (ICI). (23rd October 2018) Authors: Hierro, C; Matos, I; Martin-Liberal, J; Ochoa De Olza Amat, M; Felip, E; Costa Rivas, M; Vieito Villar, M; Brana, I; Azaro, A; Perez-Gago, M C; Gros, A; Carles, J; Oaknin, A; Macarulla, T; Saura, C; pardo, N; Muñoz-Couselo, E; Tabernero, J; Dienstmann, R; Garralda, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 22P Early changes in plasma cell-free DNA (cfDNA) as a predictive biomarker of immune checkpoint inhibitors (ICIs) efficacy. (15th December 2019) Authors: Garcia, I Matos; Moreno, A; Arenillas, C; Carbo, C Hierro; Munoz-Cosuelo, E; Martin-Liberal, J; Braña, I; Villar, M Vieito; Azaro, A; Gadea, O Saavedra Santa; Gonzalez, I Gardeazabal; Javier, R; Roger, B; Elez, E; Felip, E; Dienstmann, R; Gros, A; Tabernero, J; Toledo, R D A; Garralda, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗